- Marco Rubio: U.S. at social, moral crossroads
- ‘We’re coming for you, Barack Obama’: Top U.S. official discloses threat from ISIL
- White flags baffle NYPD: ‘We’re lucky it wasn’t a bomb’
- N.Y. Gov. Cuomo’s office interfered with, pressured corruption commission: report
- Brit lawmaker: I would fire on Israel if I lived in Gaza
- VA apologizes to forgotten Marine veteran locked in Fla. clinic, forced to call 911
- U.S. social and economic trends on worrisome track, survey finds
- McDonald nomination unanimously referred to full Senate
- Chuck Norris honorary chairman of NRA voter registration campaign
- GOP outraged Obamacare investigators able to get coverage with fake IDs
Erie cancer foundation hits funding goal, to close
Question of the Day
ERIE, Pa. (AP) - The foundation named for an amateur Pennsylvania researcher who invented a device that proponents say fights cancer with radio waves is disbanding now that it’s raised nearly $17 million to help bring the technology to the brink of human trials.
Officials with the Kanzius Cancer Research Foundation announced Tuesday that they’re shutting down June 30, the Erie Times-News (http://bit.ly/1j7omy1 ) reported.
Kanzius was diagnosed with cancer in 2002 and came up with his theory about treating the disease noninvasively two years later. Kanzius‘ device uses radio waves to heat and destroy cancer cells without harming healthy cells nearby.
Kanzius had no medical background but built the device after researching cancer and learning about radio waves. He was formerly a partner at Erie’s Jet Broadcasting Co.
The foundation’s board said in a statement that the group “reached the peak of its progress” and has “funded all of the research of the Kanzius Noninvasive Radiowave Cancer Treatment necessary to launch human trials.”
The University of Pittsburgh Medical Center and the M.D. Anderson Cancer Center in Houston have experimented with the device and AkesoGenX, the company that now owns the technology patents, will soon apply to the Food and Drug Administration for permission to conduct human trials.
If the FDA rejects the application, Neidig said, the research team may try to conduct human trials in Italy.
Information from: Erie Times-News, http://www.goerie.com
TWT Video Picks
The subsidies are a hit with patients who don't exist
- Democratic Sen. John Walsh plagiarized War College master's thesis: report
- Obama orders Pentagon advisers to Ukraine
- House task force to recommend National Guard on border, faster deportations
- 'We're coming for you, Barack Obama': Top U.S. official discloses threat from ISIL terrorists
- Hezbollah warring in Syria could join fight against Israel
- Netanyahu's Wikipedia page replaced with giant Palestinian flag
- Hamas orders civilians to die in Israeli airstrikes
- Pro-Russia rebel commander suggests passengers died days before Malaysian flight
- TYRRELL: The birth of a new alignment in the Middle East
- Despite rhetoric, gun prosecutions plummet under Obama
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq